A Wuhan man reported fever, dyspnea and myalgia since January 28.
On the 10th of February his condition worsened, and he experienced confusion and disorientation.
Analytical tests showed low leukocyte (3.3×109/L) and▁lymphocytic (0.8×109/L).
Cranial CT scan was normal, whereas chest CT showed several subpleural ground glass opacities.
The patient was positive for SARS-CoV-2 and discharged to our institution.
On physical examination, vital signs were stable without altered consciousness.
Signs of meningeal syndrome (rigidity of the neck, Kig sign and Brudzinski sign) and Babinski sign were observed.
Arterial gas showed a PO2/FiO2 ratio of 240 mmHg.
This COVID-19 patient was treated with arbidol and orientation therapy, but her disorientation did not improve.
On February 16, a lumbar puncture was performed; the cerebrospinal fluid (CSF) pressure was 220 mmHg.
The CSF analytical tests showed white blood cell (0.001 × 109/L), protein (0.27 g/L), ADA (0.17 U/L) and glucose (3.14 mmol/L) within normal limits.
A negative SARS-CoV-2 test was also performed with the CSF sample.
The patient showed no signs of bacterial or tuberculous CNS infection.
After a careful neurological evaluation, encephalitis associated with SARS-CoV-2 infection was determined.
At these times, the treatment was basically symptomatic, which included administration of mannitol.
Interestingly, the patient's awareness improved from February 20, and the chest CT scan indicated an improvement in ground glass opacities.
His conscience was entirely of the March 24.
Two consecutive pharyngeal swab tests were negative for SARS-CoV-2.
The patient was discharged on February 27th.
